Skip to content
value.today

Syncromune, Inc.

Total raised
$159 M
2 rounds on record
Latest round
$145 M
Dec 2024
First round on record
May 2022
Today
Private
No later event on record

Funding rounds

2 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Syncromune, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Dec 2024$145 MNo. 2$50 to $250 million

Syncromune, Inc.: Raise no. 2, Dec 2024

Investors in this round

77 investors had bought by the notice of May 11, 2026: 77 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$145 M of $145 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Agustin J. Gago · Executive Officer
  • Charles J. Link · Executive Officer, Director
  • Eamonn J. Hobbs · Executive Officer, Director
  • Joseph J. Gerardi · Executive Officer
  • Kerri-Ann L. Millar · Executive Officer
  • Stephen L. Dale · Executive Officer
  • Douglas G. Watson · Director
  • Jeffrey L. Cleland · Director
  • Joseph C. Maroon · Director
  • Norman L. Schwartz · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “Total Offering Amount and Total Amount Sold each includes the conversion of outstanding convertible securities.”

Signed by Eamonn Hobbs, Chief Executive Officer. Source: SEC Form D and 2 amendments, newest notice filed May 11, 2026. Read the notice at the SEC.

equitySEC
May 2022$14 MNo. 1$10 to $50 million

Syncromune, Inc.: Raise no. 1, May 2022

Investors in this round

44 investors had bought by the notice of Oct 6, 2023: 44 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$14 M of $20 M offered; $6 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity, options or other rights to buy securities
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Agustin J. Gago · Executive Officer
  • Charles J. Link · Executive Officer, Director
  • Eamonn J. Hobbs · Executive Officer, Director
  • Joseph J. Gerardi · Executive Officer
  • Douglas G. Watson · Director
  • Jeffrey L. Cleland · Director
  • Joseph C. Maroon · Director
  • Norman L. Schwartz · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Eamonn P. Hobbs, Chief Executive Officer. Source: SEC Form D and 1 amendment, newest notice filed Oct 6, 2023. Read the notice at the SEC.

equity, optionsSEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Syncromune, Inc. chose not to state its revenue in its newest notice of a funding round (May 2026).

    SEC Form D · May 2026

  • The industry group it chose in its notices: Other Health Care.

    SEC Form D · May 2026

That is all the official record says: Syncromune, Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Syncromune, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 2 rounds above had up to 77 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Syncromune, Inc.
NameRoleNamed in
Agustin J. GagoExecutive officerMay 2026
Charles J. LinkExecutive officerMay 2026
Eamonn J. HobbsExecutive officerMay 2026
Joseph J. GerardiExecutive officerMay 2026
Kerri-Ann L. MillarExecutive officerMay 2026
Stephen L. DaleExecutive officerMay 2026
Gregory J. ChampionExecutive officerDec 2024
Jeffrey J. KrawsExecutive officerDec 2024
Charles J. LinkDirectorMay 2026
Douglas G. WatsonDirectorMay 2026
Eamonn J. HobbsDirectorMay 2026
Jeffrey L. ClelandDirectorMay 2026
Joseph C. MaroonDirectorMay 2026
Norman L. SchwartzDirectorMay 2026